• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Ghosal, N
    Mais, Kathleen L
    Shenjere, Patrick
    Julyan, Peter J
    Hastings, David L
    Ward, Timothy H
    Ryder, W David J
    Bruce, I
    Homer, Jarrod J
    Slevin, Nicholas J
    Affiliation
    Glan Clwyd Hospital, Rhyl, Denbighshire LL18 5UJ, United Kingdom. niladrighosal@hotmail.com
    Issue Date
    2011-10
    
    Metadata
    Show full item record
    Abstract
    Patients with adenoid cystic carcinoma of the salivary glands show over-expression of KIT in a high proportion of cases. Options for systemic treatment are limited in locally advanced and metastatic disease. We explored the efficacy of imatinib and cisplatin combined in this group of patients. A Gehan's two-stage, phase II trial was conducted on 28 patients. Those with progressive, locally advanced, and metastatic disease with an over-expression of KIT were treated with single agent imatinib 800 mg daily for two months, followed by a combination of imatinib 400mg daily and cisplatin 80 mg/m(2) at four-weekly intervals for six cycles. This was followed by maintenance single agent imatinib 400mg daily until the disease progressed. Response was monitored using fluorodeoxyglucose positron emission tomography (FDG-PET) and morphological imaging using computed tomography, magnetic resonance, and chest radiographs (CT/MRI/CXR). Morphological imaging showed partial response in three of 28 patients, and five patients showed a response on FDG-PET. In addition, 19 patients had useful stabilisation of disease. The median time to progression and overall survival was 15 months (range 1-43) and 35 months (range 1-75), respectively. The combination of imatinib and cisplatin was reasonably well tolerated. This combination may provide stabilisation in locally advanced and metastatic adenoid cystic carcinoma of the salivary glands.
    Citation
    Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma. 2011, 49 (7):510-5 Br J Oral Maxillofac Surg
    Journal
    British Journal of Oral and Maxillofacial Surgery
    URI
    http://hdl.handle.net/10541/226173
    DOI
    10.1016/j.bjoms.2010.09.013
    PubMed ID
    21071117
    Type
    Article
    Language
    en
    ISSN
    1532-1940
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.bjoms.2010.09.013
    Scopus Count
    Collections
    All Christie Publications
    All Paterson Institute for Cancer Research
    Pathology
    Clinical Oncology

    entitlement

    Related articles

    • A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands.
    • Authors: Pfeffer MR, Talmi Y, Catane R, Symon Z, Yosepovitch A, Levitt M
    • Issue date: 2007 Jan
    • Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study.
    • Authors: Hotte SJ, Winquist EW, Lamont E, MacKenzie M, Vokes E, Chen EX, Brown S, Pond GR, Murgo A, Siu LL
    • Issue date: 2005 Jan 20
    • Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: report of two successfully treated cases.
    • Authors: Alcedo JC, Fábrega JM, Arosemena JR, Urrutia A
    • Issue date: 2004 Sep
    • Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate.
    • Authors: Lin CH, Yen RF, Jeng YM, Tzen CY, Hsu C, Hong RL
    • Issue date: 2005 Dec
    • Epirubicin, cisplatin and protracted venous infusion 5-Fluorouracil chemotherapy for advanced salivary adenoid cystic carcinoma.
    • Authors: Ross PJ, Teoh EM, A'hern RP, Rhys-Evans PH, Harrington KJ, Nutting CM, Gore ME
    • Issue date: 2009 May
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.